Product category:
HTS and combinatorial chemistry equipment
News Release from: Guava Technologies | Subject: PCA-96
Edited by the Laboratorytalk Editorial
Team on 28 April 2003
High-throughput screening of cells and
compounds
Personal cell analysis system streamlines cell monitoring and screening in a single, powerful system that anyone in the laboratory can use
Guava Technologies has announced what it says is a breakthrough in accurate and rapid high-throughput screening of cell lines and compounds The new Guava personal cell analysis-96 (PCA-96) system streamlines cell monitoring and screening in a single, powerful system that anyone in the lab can use
This article was originally published on Laboratorytalk on 1 Apr 2005 at 8.00am (UK)
Related stories
Rapid, accurate determination of Baculovirus titre
Technical paper describes a novel flow cytometric type assay that provides rapid, accurate determination of Baculovirus titres
Streamlining cell monitoring and screening
Only a few microlitres of samples, such as cultured and blood cells, are required for each experiment, saving precious cells and reagents and reducing potentially hazardous biological waste
The Guava PCA-96 is the first affordable, ultra-compact system to enable rapid, high-throughput screening of cell lines and compounds in both 96-well microplate and microcentrifuge tube format.
PCA-96 system simplifies cell monitoring and screening using samples only a few microlitres in volume, experiments can be started sooner and finished faster, with minimal waste, streamlining the entire R and D process.
The Guava PCA-96 offers turnkey operation in an integrated system consisting of the compact PCA-96 instrument, software to automatically analyse and archive data, and optimised reagents.
Current screening assays available for the Guava PCA-96 include cell counting and viability assay, protein expression assay and apoptosis assay.
To accommodate evolving assay needs, the Guava PCA-96 system is expandable so that users can add new applications in the future.
"The Guava PCA-96 has given us insights into a cell-based screen that we could not have achieved with conventional high throughput screening (HTS) assays," said Jill Gregory, staff scientist at Genzyme, an early user of the Guava PCA-96.
"It has great value not only for assay development and drug lead optimisation, but is also a credible screening instrument giving high content readouts from a single well.".
• Guava Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
